WSD0628

ATM inhibitor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WSD0628, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma [Phase 1]

See pricing